Skip to main content
Erschienen in: Journal of Clinical Immunology 5/2016

12.04.2016 | Letter to Editor

A Difficult and Rare Diagnosis of Autoimmune Enteropathy in a Patient Affected by Down Syndrome

verfasst von: Anne Depince-Berger, Clara Cremilieux, Melanie Rinaudo-Gaujous, Christian Genin, Benedicte de Freminville, Claude Lambert, J. Bruneau, Stephane Paul

Erschienen in: Journal of Clinical Immunology | Ausgabe 5/2016

Einloggen, um Zugang zu erhalten

Abstract

Patients with Down syndrome are more susceptible to autoimmune pathologies, in particular endocrine or digestive diseases such as celiac disease. Autoimmune enteropathy is another form of digestive autoimmune disease, non-gluten-dependant, more often diagnosed in male neonates with immunodysregulation and polyendocrinopathy such as the Immunodysregulation, Polyendocrinopathy, Enteropathy, X-linked syndrome. It also exists in the adult, but this pathology is less known and therefore frequently under-diagnosed. Clinical manifestations are similar to celiac disease, but not improved after a gluten-free diet. Autoimmune enteropathy is frequently associated with other autoimmune diseases, such as thyroiditis, myasthenia gravis, lupus or immune deficiencies, as Common Variable Immunodeficiency. Pathological analysis of intestinal biopsies can frequently distinguish autoimmune enteropathy and celiac disease. Autoimmune enteropathy usually has an important lymphoplasmacytic infiltration of the mucosa and a lack of intraepithelial lymphocytes in the gastrointestinal mucosal surface, while celiac disease usually has a polymorph infiltration of the mucosa and an important intraepithelial lymphocytes infiltration. Nevertheless, the two pathological patterns may overlap. Here we report the first case of a patient with Down syndrome associated to autoimmune enteropathy (initially diagnosed as celiac disease), chronic pancreatitis and cutaneous lupus erythematosus. Even if autoimmune pathologies are much more common in patients with Down syndrome, we would like to report on this rare and original association found in our patient.
Literatur
1.
Zurück zum Zitat Sherman SL, Allen EG, Bean LH, Freeman SB. Epidemiology of down syndrome. Ment Retard Dev Disabil Res Rev. 2007;13(3):221–7.CrossRefPubMed Sherman SL, Allen EG, Bean LH, Freeman SB. Epidemiology of down syndrome. Ment Retard Dev Disabil Res Rev. 2007;13(3):221–7.CrossRefPubMed
2.
Zurück zum Zitat Carnicer J, Farré C, Varea V, Vilar P, Moreno J, Artigas J. Prevalence of coeliac disease in Down’s syndrome. Eur J Gastroenterol Hepatol. 2001;13(3):263–7.CrossRefPubMed Carnicer J, Farré C, Varea V, Vilar P, Moreno J, Artigas J. Prevalence of coeliac disease in Down’s syndrome. Eur J Gastroenterol Hepatol. 2001;13(3):263–7.CrossRefPubMed
3.
Zurück zum Zitat Anwar AJ, Walker JD, Frier BM. Type 1 diabetes mellitus and Down’s syndrome: prevalence, management and diabetic complications. Diabet Med J Br Diabet Assoc. 1998;15(2):160–3.CrossRef Anwar AJ, Walker JD, Frier BM. Type 1 diabetes mellitus and Down’s syndrome: prevalence, management and diabetic complications. Diabet Med J Br Diabet Assoc. 1998;15(2):160–3.CrossRef
4.
Zurück zum Zitat Bull MJ. Health Supervision for Children with Down Syndrome. Pediatrics. 2011;128(2):393–406.CrossRefPubMed Bull MJ. Health Supervision for Children with Down Syndrome. Pediatrics. 2011;128(2):393–406.CrossRefPubMed
5.
Zurück zum Zitat Giménez-Barcons M, Casteràs A, del Armengol ,MP, Porta E, Correa PA, Marín A, et al. Autoimmune predisposition in Down syndrome may result from a partial central tolerance failure due to insufficient intrathymic expression of AIRE and peripheral antigens. J Immunol Baltim Md. 2014;193(8):3872–9. Giménez-Barcons M, Casteràs A, del Armengol ,MP, Porta E, Correa PA, Marín A, et al. Autoimmune predisposition in Down syndrome may result from a partial central tolerance failure due to insufficient intrathymic expression of AIRE and peripheral antigens. J Immunol Baltim Md. 2014;193(8):3872–9.
7.
Zurück zum Zitat Ruch W, Schürmann K, Gordon P, Bürgin-Wolff A, Girard J. Coexistent coeliac disease, Graves’ disease and diabetes mellitus type 1 in a patient with down syndrome. Eur J Pediatr. 1985;144(1):89–90.CrossRefPubMed Ruch W, Schürmann K, Gordon P, Bürgin-Wolff A, Girard J. Coexistent coeliac disease, Graves’ disease and diabetes mellitus type 1 in a patient with down syndrome. Eur J Pediatr. 1985;144(1):89–90.CrossRefPubMed
8.
Zurück zum Zitat Bentley D. A case of Down’s syndrome complicated by retinoblastoma and celiac disease. Pediatrics. 1975;56(1):131–3.PubMed Bentley D. A case of Down’s syndrome complicated by retinoblastoma and celiac disease. Pediatrics. 1975;56(1):131–3.PubMed
9.
Zurück zum Zitat Rubio-Tapia A, Hill ID, Kelly CP, Calderwood AH, Murray ,JA. American college of gastroenterology clinical guideline: Diagnosis and management of celiac disease. Am J Gastroenterol. 2013;108(5):656–77.CrossRefPubMedPubMedCentral Rubio-Tapia A, Hill ID, Kelly CP, Calderwood AH, Murray ,JA. American college of gastroenterology clinical guideline: Diagnosis and management of celiac disease. Am J Gastroenterol. 2013;108(5):656–77.CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Persic M, Dessardo S, Subat-Dezulović M, Ahel V. Roz˘manić V. down syndrome and Crohn’s disease: an extremely rare association. Pediatr Int. 2001;43(5):519–21.CrossRefPubMed Persic M, Dessardo S, Subat-Dezulović M, Ahel V. Roz˘manić V. down syndrome and Crohn’s disease: an extremely rare association. Pediatr Int. 2001;43(5):519–21.CrossRefPubMed
11.
Zurück zum Zitat Burgess JN, Kelly KA. Regional enteritis and Down’s syndrome. Minn Med. 1971;54(10):793–4.PubMed Burgess JN, Kelly KA. Regional enteritis and Down’s syndrome. Minn Med. 1971;54(10):793–4.PubMed
12.
Zurück zum Zitat Muniraj T, Aslanian HR, Farrell J, Jamidar PA. Chronic pancreatitis, a comprehensive review and update. Part II: diagnosis, complications, and management. Dis Mon. 2015;61(1):5–37.CrossRefPubMed Muniraj T, Aslanian HR, Farrell J, Jamidar PA. Chronic pancreatitis, a comprehensive review and update. Part II: diagnosis, complications, and management. Dis Mon. 2015;61(1):5–37.CrossRefPubMed
13.
Zurück zum Zitat Freeman HJ. Pancreatic endocrine and exocrine changes in celiac disease. World J Gastroenterol WJG. 2007;13(47):6344–6.CrossRefPubMed Freeman HJ. Pancreatic endocrine and exocrine changes in celiac disease. World J Gastroenterol WJG. 2007;13(47):6344–6.CrossRefPubMed
14.
Zurück zum Zitat Carroccio A, Iacono G, Montalto G, Cavataio F, Di Marco C, Balsamo V, et al. Exocrine pancreatic function in children with coeliac disease before and after a gluten free diet. Gut. 1991;32(7):796–9.CrossRefPubMedPubMedCentral Carroccio A, Iacono G, Montalto G, Cavataio F, Di Marco C, Balsamo V, et al. Exocrine pancreatic function in children with coeliac disease before and after a gluten free diet. Gut. 1991;32(7):796–9.CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Ugazio AG, Maccario R, Notarangelo LD, Burgio GR. Immunology of down syndrome: a review. Am J Med Genet Suppl. 1990;7:204–12.PubMed Ugazio AG, Maccario R, Notarangelo LD, Burgio GR. Immunology of down syndrome: a review. Am J Med Genet Suppl. 1990;7:204–12.PubMed
16.
Zurück zum Zitat Kusters MAA, Verstegen RHJ, Gemen EFA, de Vries E. Intrinsic defect of the immune system in children with down syndrome: a review. Clin Exp Immunol. 2009;156(2):189–93.CrossRefPubMedPubMedCentral Kusters MAA, Verstegen RHJ, Gemen EFA, de Vries E. Intrinsic defect of the immune system in children with down syndrome: a review. Clin Exp Immunol. 2009;156(2):189–93.CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Mårild K, Stephansson O, Grahnquist L, Cnattingius S, Söderman G, Ludvigsson JF. Down syndrome is associated with elevated risk of celiac disease: a nationwide case-control study. J Pediatr. 2013;163(1):237–42.CrossRefPubMed Mårild K, Stephansson O, Grahnquist L, Cnattingius S, Söderman G, Ludvigsson JF. Down syndrome is associated with elevated risk of celiac disease: a nationwide case-control study. J Pediatr. 2013;163(1):237–42.CrossRefPubMed
18.
Zurück zum Zitat Kaukinen K, Partanen J, Mäki M, Collin P. HLA-DQ typing in the diagnosis of celiac disease. Am J Gastroenterol. 2002;97(3):695–9.CrossRefPubMed Kaukinen K, Partanen J, Mäki M, Collin P. HLA-DQ typing in the diagnosis of celiac disease. Am J Gastroenterol. 2002;97(3):695–9.CrossRefPubMed
19.
Zurück zum Zitat Husby S, Koletzko S, Korponay-Szabó IR, Mearin ML, Phillips A, Shamir R, et al. European Society for Pediatric Gastroenterology, Hepatology, and nutrition guidelines for the diagnosis of coeliac disease. J Pediatr Gastroenterol Nutr. 2012;54(1):136–60.CrossRefPubMed Husby S, Koletzko S, Korponay-Szabó IR, Mearin ML, Phillips A, Shamir R, et al. European Society for Pediatric Gastroenterology, Hepatology, and nutrition guidelines for the diagnosis of coeliac disease. J Pediatr Gastroenterol Nutr. 2012;54(1):136–60.CrossRefPubMed
21.
Zurück zum Zitat Jevon GP, Madhur R. Endoscopic and histologic findings in pediatric inflammatory bowel disease. Gastroenterol Hepatol. 2010;6(3):174–80. Jevon GP, Madhur R. Endoscopic and histologic findings in pediatric inflammatory bowel disease. Gastroenterol Hepatol. 2010;6(3):174–80.
22.
Zurück zum Zitat McCarthy DM, Katz SI, Gazze L, Waldmann TA, Nelson DL, Strober W. Selective IgA Deficiency Associated with Total Villous Atrophy of the Small Intestine and an Organ-Specific Anti-Epithelial Cell Antibody. J Immunol. 1978;120(3):932–8.PubMed McCarthy DM, Katz SI, Gazze L, Waldmann TA, Nelson DL, Strober W. Selective IgA Deficiency Associated with Total Villous Atrophy of the Small Intestine and an Organ-Specific Anti-Epithelial Cell Antibody. J Immunol. 1978;120(3):932–8.PubMed
23.
Zurück zum Zitat Unsworth DJ, Walker-Smith JA. Autoimmunity in diarrhoeal disease. J Pediatr Gastroenterol Nutr. 1985;4(3):375–80.CrossRefPubMed Unsworth DJ, Walker-Smith JA. Autoimmunity in diarrhoeal disease. J Pediatr Gastroenterol Nutr. 1985;4(3):375–80.CrossRefPubMed
24.
Zurück zum Zitat Cunningham-Rundles C, Bodian C. Common variable immunodeficiency: clinical and immunological features of 248 patients. Clin Immunol Orlando Fla. 1999;92(1):34–48.CrossRef Cunningham-Rundles C, Bodian C. Common variable immunodeficiency: clinical and immunological features of 248 patients. Clin Immunol Orlando Fla. 1999;92(1):34–48.CrossRef
25.
Zurück zum Zitat Malamut G, Verkarre V, Suarez F, Viallard J-F, Lascaux A-S, Cosnes J, et al. The enteropathy associated with common variable immunodeficiency: the delineated frontiers with celiac disease. Am J Gastroenterol. 2010;105(10):2262–75.CrossRefPubMed Malamut G, Verkarre V, Suarez F, Viallard J-F, Lascaux A-S, Cosnes J, et al. The enteropathy associated with common variable immunodeficiency: the delineated frontiers with celiac disease. Am J Gastroenterol. 2010;105(10):2262–75.CrossRefPubMed
27.
Zurück zum Zitat Greenson JK. The biopsy pathology of non-coeliac enteropathy. Histopathology. 2015;66(1):29–36.CrossRefPubMed Greenson JK. The biopsy pathology of non-coeliac enteropathy. Histopathology. 2015;66(1):29–36.CrossRefPubMed
28.
29.
Zurück zum Zitat Kobayashi I, Imamura K, Yamada M, Okano M, Yara A, Ikema S, et al. A 75-kD autoantigen recognized by sera from patients with X-linked autoimmune enteropathy associated with nephropathy. Clin Exp Immunol. 1998;111(3):527–31.CrossRefPubMedPubMedCentral Kobayashi I, Imamura K, Yamada M, Okano M, Yara A, Ikema S, et al. A 75-kD autoantigen recognized by sera from patients with X-linked autoimmune enteropathy associated with nephropathy. Clin Exp Immunol. 1998;111(3):527–31.CrossRefPubMedPubMedCentral
30.
Zurück zum Zitat Caviglia GP, Pantaleoni S, Touscoz GA, Adriani A, Rosso C, Smedile A, et al. Fecal calprotectin is an effective diagnostic tool that differentiates inflammatory from functional intestinal disorders. Scand J Gastroenterol. 2014;49(12):1419–24.CrossRefPubMed Caviglia GP, Pantaleoni S, Touscoz GA, Adriani A, Rosso C, Smedile A, et al. Fecal calprotectin is an effective diagnostic tool that differentiates inflammatory from functional intestinal disorders. Scand J Gastroenterol. 2014;49(12):1419–24.CrossRefPubMed
31.
Zurück zum Zitat Bouhnik Y. Ac anti-Saccharomyces cerevisiae. Revue Praticien; 2005. Bouhnik Y. Ac anti-Saccharomyces cerevisiae. Revue Praticien; 2005.
32.
Zurück zum Zitat Akram S, Murray JA, Pardi DS, Alexander GL, Schaffner JA, Russo PA, et al. Adult autoimmune enteropathy: Mayo Clinic Rochester experience. Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc. 2007;5(11):1282–90 .quiz 1245 Akram S, Murray JA, Pardi DS, Alexander GL, Schaffner JA, Russo PA, et al. Adult autoimmune enteropathy: Mayo Clinic Rochester experience. Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc. 2007;5(11):1282–90 .quiz 1245
34.
Zurück zum Zitat Pellegrini FP, Marinoni M, Frangione V, Tedeschi A, Gandini V, Ciglia F, et al. Down syndrome, autoimmunity and T regulatory cells. Clin Exp Immunol. 2012;169(3):238–43.CrossRefPubMedPubMedCentral Pellegrini FP, Marinoni M, Frangione V, Tedeschi A, Gandini V, Ciglia F, et al. Down syndrome, autoimmunity and T regulatory cells. Clin Exp Immunol. 2012;169(3):238–43.CrossRefPubMedPubMedCentral
35.
Zurück zum Zitat Skogberg G, Lundberg V, Lindgren S, Gudmundsdottir J, Sandström K, Kämpe O, et al. Altered Expression of Autoimmune Regulator in Infant Down Syndrome Thymus, a Possible Contributor to an Autoimmune Phenotype. J Immunol Author Choice. 2014;193(5):2187–95.CrossRef Skogberg G, Lundberg V, Lindgren S, Gudmundsdottir J, Sandström K, Kämpe O, et al. Altered Expression of Autoimmune Regulator in Infant Down Syndrome Thymus, a Possible Contributor to an Autoimmune Phenotype. J Immunol Author Choice. 2014;193(5):2187–95.CrossRef
36.
Zurück zum Zitat Cuadrado E, Barrena MJ. Immune dysfunction in Down’s syndrome: primary immune deficiency or early senescence of the immune system? Clin Immunol Immunopathol. 1996;78(3):209–14.CrossRefPubMed Cuadrado E, Barrena MJ. Immune dysfunction in Down’s syndrome: primary immune deficiency or early senescence of the immune system? Clin Immunol Immunopathol. 1996;78(3):209–14.CrossRefPubMed
37.
Zurück zum Zitat Kusters MA, Verstegen RH, de Vries E. Down Syndrome: Is It Really Characterized by Precocious Immunosenescence? Aging Dis. 2 déc 2011; 2(6):538–45. Kusters MA, Verstegen RH, de Vries E. Down Syndrome: Is It Really Characterized by Precocious Immunosenescence? Aging Dis. 2 déc 2011; 2(6):538–45.
38.
Zurück zum Zitat Sohachi Nanjo JN. Immune-mediated protein-losing enteropathy with down syndrome. Intern Med Tokyo Jpn. 2014;53(20):2301–5.CrossRef Sohachi Nanjo JN. Immune-mediated protein-losing enteropathy with down syndrome. Intern Med Tokyo Jpn. 2014;53(20):2301–5.CrossRef
Metadaten
Titel
A Difficult and Rare Diagnosis of Autoimmune Enteropathy in a Patient Affected by Down Syndrome
verfasst von
Anne Depince-Berger
Clara Cremilieux
Melanie Rinaudo-Gaujous
Christian Genin
Benedicte de Freminville
Claude Lambert
J. Bruneau
Stephane Paul
Publikationsdatum
12.04.2016
Verlag
Springer US
Erschienen in
Journal of Clinical Immunology / Ausgabe 5/2016
Print ISSN: 0271-9142
Elektronische ISSN: 1573-2592
DOI
https://doi.org/10.1007/s10875-016-0280-7

Weitere Artikel der Ausgabe 5/2016

Journal of Clinical Immunology 5/2016 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.